Sirio Pharma Co., Ltd. (300791.SZ)
CNY 28.09
(-0.46%)
CNY 28.09
(-0.46%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.56 CNY | 32.2% |
| 2022 | 1.18 CNY | -8.53% |
| 2021 | 1.29 CNY | -9.79% |
| 2020 | 1.43 CNY | 81.01% |
| 2019 | 0.79 CNY | -47.68% |
| 2018 | 1.51 CNY | 96.1% |
| 2017 | 0.77 CNY | -85.22% |
| 2016 | 5.21 CNY | 1140.48% |
| 2015 | 0.42 CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.35 CNY | -33.96% |
| 2024 Q3 | 0.37 CNY | -27.45% |
| 2024 Q2 | 0.51 CNY | 45.71% |
| 2023 Q1 | 0.16 CNY | -20.0% |
| 2023 FY | - CNY | 32.2% |
| 2023 Q4 | 0.53 CNY | 12.77% |
| 2023 Q3 | 0.47 CNY | 17.5% |
| 2023 Q2 | 0.40 CNY | 150.0% |
| 2022 FY | - CNY | -8.53% |
| 2022 Q4 | 0.20 CNY | -45.95% |
| 2022 Q2 | 0.53 CNY | 462.63% |
| 2022 Q1 | 0.09 CNY | -27.54% |
| 2022 Q3 | 0.37 CNY | -30.19% |
| 2021 FY | - CNY | -9.79% |
| 2021 Q1 | 0.32 CNY | -20.0% |
| 2021 Q2 | 0.49 CNY | 53.12% |
| 2021 Q3 | 0.23 CNY | -53.06% |
| 2021 Q4 | 0.13 CNY | -43.48% |
| 2020 Q2 | 0.41 CNY | 46.43% |
| 2020 Q4 | 0.40 CNY | 17.65% |
| 2020 Q1 | 0.28 CNY | -45.1% |
| 2020 Q3 | 0.34 CNY | -17.07% |
| 2020 FY | - CNY | 81.01% |
| 2019 Q3 | 0.26 CNY | 13.04% |
| 2019 FY | - CNY | -47.68% |
| 2019 Q1 | 0.27 CNY | -46.0% |
| 2019 Q2 | 0.23 CNY | -14.81% |
| 2019 Q4 | 0.51 CNY | 96.15% |
| 2018 Q4 | 0.50 CNY | 25.0% |
| 2018 Q3 | 0.40 CNY | 0.0% |
| 2018 FY | - CNY | 96.1% |
| 2017 FY | - CNY | -85.22% |
| 2016 FY | - CNY | 1140.48% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |